Advertising Exhibitors Gallery
Advertising Exhibitors Gallery
IIR's Clinical Trials Congress
February 2527, 2008
Loews Royal Pacific Resort, Orlando, FL
ALMAC Clinical Technologies
Booth Number: 408
1040 Stony Hill Road
Suite 200
Yardley, PA 19067
Phone: 267-685-4284
Email: integrated@almacgroup.com
www: www.almacgroup.com
EResearchTechnology, Inc.
Booth Number: 207
30 South 17th Street
Philadelphia, PA 19103
Phone: 215-972-0420
Fax:215-972-0414
Email: eresearch@ert.com
www: www.ert.com
MedNet Solutions, Inc.
Booth Number: 506
601 Carlson Parkway
Suite 605
Minnetonka, MN 55305
Phone: 763-258-2735
Fax: 763-258-2737
Email: info@mednetstudy.com
www: www.mednetstudy.com
United BioSource Corporation
Booth Number: 505
7501 Wisconsin Avenue
Suite 705
Bethesda, MD 20814
Phone: 866-458-1096
Fax: 240-644-0421
Email: info@unitedbiosource.com
www: www.unitedbiosource.com
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.